R. Bryan B. Bell, MD, DDS
Portland, OR 97213
Providence Cancer Institute Franz Head and Neck Clinic
4805 Northeast Glisan Street, Suite 11N-7, Portland, OR 97213
Insurances Accepted
This information provides an overview of accepted insurance plan types. Coverage may vary by specific plan. Please verify your with your insurance provider before visiting us for care.
About R. Bryan B. Bell
R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed), is the Executive Medical Director of Providence Cancer Institute of Oregon, Director and Member of Earle A. Chiles Research Institute, and holds the Walter J. Urba Chair for Cancer Research in Portland, Oregon. In these roles, he oversees oncology services and research teams that deliver care to more than 6,000 cancer patients annually in 32 clinics and eight Oregon hospitals.
As an internationally recognized head and neck surgeon, Dr. Bell has led pioneering research and clinical efforts to integrate immunotherapy into the neoadjuvant setting. Using his surgical practice to conduct clinical trials, Dr. Bell’s research bridges basic, translational and clinical activities. In addition, he has worked to develop technologically advanced methods to enhance the effectiveness of head and neck cancer surgery, including virtual surgical planning, transoral robotic surgery and sentinel lymph node biopsy. Dr. Bell’s work has been published in more than 350 scientific articles and book chapters, and he is co-author of two major textbooks, including "Oral, Head and Neck Oncology and Reconstructive Surgery".
For almost three decades, Dr. Bell has been active in educating the next generation of surgeons. He has trained or mentored dozens of surgical residents, fellows and students in head and neck oncologic and reconstructive surgery. Dr. Bell has served on National Institutes of Health Head and Neck Steering Committee’s Immunotherapy Clinical Trials Planning Group and the Task Force on Previously Untreated/Locally Advanced (PULA) Disease. In addition, he has held numerous leadership positions and board appointments within various professional and non-profit organizations. Amongst his honors, Dr. Bell has been awarded Fellowship in the Royal College of Surgeons of Edinburgh, Ad Hominem.
Creighton University School of Medicine
1995
Head and Neck Surgical Associates
2002
Legacy Portland Hospitals
2003
Head and Neck Surgical Associates
2002
University of North Carolina
1997
University of North Carolina
2001
American Academy of Craniomaxillofacial Surgeons
American College of Surgeons
American Head and Neck Society
Association of Clinical Oncology
International Academy of Oral Oncology
Society for Immunotherapy of Cancer
- American Board of Oral and Maxillofacial Surgery, Oral and Maxillofacial Surgery
- Patient-Specific Printed Plates Improve Surgical Accuracy In Vitro.
- Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease.
- Use of Intraoperative Computed Tomography in Craniomaxillofacial Trauma Surgery.
- Relationships matter in oral cancer: will single-stain immunohistochemistry become irrelevant in the age of multispectral imaging?
- STING expression and response to treatment with STING ligands in premalignant and malignant disease.
- Functional Anatomic Computer Engineered Surgery Protocol for the Management of Self-Inflicted Gunshot Wounds to the Maxillofacial Skeleton.
- Updates in Management of Craniomaxillofacial Gunshot Wounds and Reconstruction of the Mandible
- African Americans in Oral and Maxillofacial Surgery: Factors Affecting Career Choice, Satisfaction, and Practice Patterns.
- Multiparametric immune profiling in HPV- oral squamous cell cancer.
- Margin Analysis: Squamous Cell Carcinoma of the Oropharynx.
- Head and neck surgeons at the vanguard of immunotherapy.
- Erratum to 'Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy' [Oral Oncol. 61 (2016) 166-176].
- Surgical Navigation: A Systematic Review of Indications, Treatments, and Outcomes in Oral and Maxillofacial Surgery.
- Virtual Surgical Planning and Intraoperative Imaging in Management of Ballistic Facial and Mandibular Condylar Injuries.
- Surgical Splint Design Influences Transverse Expansion in Segmental Maxillary Osteotomies.
- Head and neck cancer immunology and immunotherapeutics: Basic concepts to clinical translational approaches.
- OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer.
- The fourth modality: immunotherapy for head and neck cancer hits pay dirt.
- Infinite cornucopia: The future of education and training in oral and maxillofacial surgery. Bell RB1.
- OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironment.
4805 Northeast Glisan Street, Suite 11N-7
Portland, OR 97213
Providence Medical Group - Oregon
Providence St. Vincent Medical Center